Cargando…
Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214241/ https://www.ncbi.nlm.nih.gov/pubmed/31719682 http://dx.doi.org/10.1038/s41375-019-0620-8 |
| _version_ | 1783531926529769472 |
|---|---|
| author | Bjorklund, Chad C. Kang, Jian Amatangelo, Michael Polonskaia, Ann Katz, Mark Chiu, Hsiling Couto, Suzana Wang, Maria Ren, Yan Ortiz, Maria Towfic, Fadi Flynt, J. Erin Pierceall, William Thakurta, Anjan |
| author_facet | Bjorklund, Chad C. Kang, Jian Amatangelo, Michael Polonskaia, Ann Katz, Mark Chiu, Hsiling Couto, Suzana Wang, Maria Ren, Yan Ortiz, Maria Towfic, Fadi Flynt, J. Erin Pierceall, William Thakurta, Anjan |
| author_sort | Bjorklund, Chad C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7214241 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72142412020-05-14 Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN Bjorklund, Chad C. Kang, Jian Amatangelo, Michael Polonskaia, Ann Katz, Mark Chiu, Hsiling Couto, Suzana Wang, Maria Ren, Yan Ortiz, Maria Towfic, Fadi Flynt, J. Erin Pierceall, William Thakurta, Anjan Leukemia Letter Nature Publishing Group UK 2019-11-12 2020 /pmc/articles/PMC7214241/ /pubmed/31719682 http://dx.doi.org/10.1038/s41375-019-0620-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Bjorklund, Chad C. Kang, Jian Amatangelo, Michael Polonskaia, Ann Katz, Mark Chiu, Hsiling Couto, Suzana Wang, Maria Ren, Yan Ortiz, Maria Towfic, Fadi Flynt, J. Erin Pierceall, William Thakurta, Anjan Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN |
| title | Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN |
| title_full | Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN |
| title_fullStr | Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN |
| title_full_unstemmed | Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN |
| title_short | Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN |
| title_sort | iberdomide (cc-220) is a potent cereblon e3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated crbn |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214241/ https://www.ncbi.nlm.nih.gov/pubmed/31719682 http://dx.doi.org/10.1038/s41375-019-0620-8 |
| work_keys_str_mv | AT bjorklundchadc iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT kangjian iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT amatangelomichael iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT polonskaiaann iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT katzmark iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT chiuhsiling iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT coutosuzana iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT wangmaria iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT renyan iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT ortizmaria iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT towficfadi iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT flyntjerin iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT pierceallwilliam iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn AT thakurtaanjan iberdomidecc220isapotentcereblone3ligasemodulatorwithantitumorandimmunostimulatoryactivitiesinlenalidomideandpomalidomideresistantmultiplemyelomacellswithdysregulatedcrbn |